RELEAP: reinforcement-enhanced label-efficient active phenotyping for electronic health records.
1/5 보강
[OBJECTIVES] Electronic health record (EHR) phenotyping often relies on noisy proxy labels, which undermine the reliability of downstream risk prediction.
APA
Yang Y, Pollak KI, et al. (2026). RELEAP: reinforcement-enhanced label-efficient active phenotyping for electronic health records.. JAMIA open, 9(1), ooag019. https://doi.org/10.1093/jamiaopen/ooag019
MLA
Yang Y, et al.. "RELEAP: reinforcement-enhanced label-efficient active phenotyping for electronic health records.." JAMIA open, vol. 9, no. 1, 2026, pp. ooag019.
PMID
41727415 ↗
Abstract 한글 요약
[OBJECTIVES] Electronic health record (EHR) phenotyping often relies on noisy proxy labels, which undermine the reliability of downstream risk prediction. Active learning can reduce annotation costs, but typical heuristics do not directly optimize downstream prediction. Our goal was to develop a framework that directly uses downstream prediction performance as feedback to guide phenotype correction and sample selection under constrained labeling budgets.
[MATERIALS AND METHODS] We propose reinforcement-enhanced label-efficient active phenotyping (RELEAP), a reinforcement learning-based active learning framework. Reinforcement-enhanced label-efficient adaptively integrates multiple querying strategies and, unlike prior methods, updates its policy based on feedback from downstream models. We evaluated RELEAP on a de-identified Duke University Health System (DUHS) cohort (2014-2024) for incident lung cancer risk prediction, using logistic regression and penalized Cox survival models. Performance was benchmarked against noisy-label baselines and single-strategy active learning.
[RESULTS] Reinforcement-enhanced label-efficient improved over the proxy-only baseline and approached oracle performance under the same budget. Logistic AUC increased from 0.774 to 0.807. Survival concordance index increased from 0.715 to 0.749. Gains were stable across iterations using downstream feedback. These trends were consistent in sex-stratified subgroup analyses (female vs male).
[DISCUSSION] By linking phenotype refinement to prediction outcomes, RELEAP learns which samples most improve downstream discrimination and calibration, offering a more principled alternative to fixed active learning rules.
[CONCLUSION] Reinforcement-enhanced label-efficient optimizes phenotype correction through downstream feedback, offering a scalable, label-efficient paradigm that reduces manual chart review and enhances the reliability of EHR-based risk prediction.
[MATERIALS AND METHODS] We propose reinforcement-enhanced label-efficient active phenotyping (RELEAP), a reinforcement learning-based active learning framework. Reinforcement-enhanced label-efficient adaptively integrates multiple querying strategies and, unlike prior methods, updates its policy based on feedback from downstream models. We evaluated RELEAP on a de-identified Duke University Health System (DUHS) cohort (2014-2024) for incident lung cancer risk prediction, using logistic regression and penalized Cox survival models. Performance was benchmarked against noisy-label baselines and single-strategy active learning.
[RESULTS] Reinforcement-enhanced label-efficient improved over the proxy-only baseline and approached oracle performance under the same budget. Logistic AUC increased from 0.774 to 0.807. Survival concordance index increased from 0.715 to 0.749. Gains were stable across iterations using downstream feedback. These trends were consistent in sex-stratified subgroup analyses (female vs male).
[DISCUSSION] By linking phenotype refinement to prediction outcomes, RELEAP learns which samples most improve downstream discrimination and calibration, offering a more principled alternative to fixed active learning rules.
[CONCLUSION] Reinforcement-enhanced label-efficient optimizes phenotype correction through downstream feedback, offering a scalable, label-efficient paradigm that reduces manual chart review and enhances the reliability of EHR-based risk prediction.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Super-selective intra-arterial dissolution therapy for lingual artery occlusion resulting due to the use of hyaluronic acid for chin augmentation: The first reported case.
- NAT10 and ac4C modification in cancer immunity and metabolism: emerging mechanisms and therapeutic potential.
- Engineering polymeric RNA scaffolds as programmable combinatorial innate immune agonists.
- HDAC11 interacts with the NuRD (MTA3) complex to transcriptionally suppress TGFβ1 expression and inhibit hepatocellular carcinoma metastasis.
- Targeting palmitoylation: A novel frontier in cancer biology and immunotherapy.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Reforming the delivery of smoking cessation: a distributional cost-effectiveness analysis of providing smoking cessation as part of targeted lung cancer screening.
- A herbal formulation inhibits growth and survival of lung cancer cells through DNA damage and apoptosis - in vitro and in vivo studies.
- Negative trial but positive lesson: reframing immunotherapy resistance from one-size-fits-all to precision strategies.
- Lung Cancer Screening in Adults: State-of-the-Art and Policy Mapping (2025).
- Retrospective dosimetric evaluation of the collapsed cone, AAA, and Acuros XB algorithms for lung cancer Halcyon VMAT plans.
- Metastatic Pancreatic Adenocarcinoma with Germline BLM and Somatic ATM Mutations: A Case Report and Review of DNA Damage Response.